Latest Insider Transactions at Moelis & CO (MC)
This section provides a real-time view of insider transactions for Moelis & CO (MC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Moelis & Co to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Moelis & Co's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 23
2023
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
31
+1.3%
|
-
|
|
Jun 23
2023
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
20
+1.34%
|
-
|
|
Jun 23
2023
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
4
+0.59%
|
-
|
|
Jun 23
2023
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
30
+1.32%
|
-
|
|
Jun 23
2023
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
19
+1.31%
|
-
|
|
Apr 27
2023
|
Eric Cantor Vice Chairman, MD |
SELL
Payment of exercise price or tax liability
|
Direct |
570
-0.33%
|
$22,800
$40.6 P/Share
|
|
Apr 27
2023
|
Eric Cantor Vice Chairman, MD |
BUY
Exercise of conversion of derivative security
|
Direct |
1,294
+0.75%
|
-
|
|
Apr 03
2023
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
13
+50.0%
|
-
|
|
Apr 03
2023
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
309
+50.0%
|
-
|
|
Apr 03
2023
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
66
+50.0%
|
-
|
|
Apr 03
2023
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
309
+50.0%
|
-
|
|
Apr 03
2023
|
Yolonda C Richardson Director |
BUY
Grant, award, or other acquisition
|
Direct |
77
+50.0%
|
-
|
|
Apr 03
2023
|
Laila Worrell |
BUY
Grant, award, or other acquisition
|
Direct |
132
+50.0%
|
-
|
|
Apr 03
2023
|
Laila Worrell |
BUY
Grant, award, or other acquisition
|
Direct |
342
+50.0%
|
-
|
|
Mar 28
2023
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
2
+1.31%
|
-
|
|
Mar 28
2023
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
30
+1.5%
|
-
|
|
Mar 28
2023
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
22
+1.49%
|
-
|
|
Mar 28
2023
|
Laila Worrell |
BUY
Grant, award, or other acquisition
|
Direct |
16
+1.54%
|
-
|
|
Mar 28
2023
|
Laila Worrell |
BUY
Grant, award, or other acquisition
|
Direct |
12
+1.51%
|
-
|
|
Mar 28
2023
|
Yolonda C Richardson Director |
BUY
Grant, award, or other acquisition
|
Direct |
28
+1.5%
|
-
|
|
Mar 28
2023
|
Yolonda C Richardson Director |
BUY
Grant, award, or other acquisition
|
Direct |
22
+1.54%
|
-
|
|
Mar 28
2023
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
10
+1.5%
|
-
|
|
Mar 28
2023
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
28
+1.5%
|
-
|
|
Mar 28
2023
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
22
+1.54%
|
-
|
|
Mar 03
2023
|
Navid Mahmoodzadegan Co-President, MD |
SELL
Open market or private sale
|
Direct |
23,323
-18.93%
|
$1,002,889
$43.05 P/Share
|
|
Mar 01
2023
|
Navid Mahmoodzadegan Co-President, MD |
SELL
Open market or private sale
|
Direct |
54,009
-30.48%
|
$2,322,387
$43.13 P/Share
|
|
Feb 28
2023
|
Navid Mahmoodzadegan Co-President, MD |
SELL
Open market or private sale
|
Direct |
52,209
-22.76%
|
$2,244,987
$43.22 P/Share
|
|
Feb 27
2023
|
Osamu R. Watanabe General Counsel, Secretary |
SELL
Open market or private sale
|
Direct |
6,130
-97.91%
|
$257,460
$42.99 P/Share
|
|
Feb 23
2023
|
Kenneth Moelis Chairman, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
80
+0.08%
|
-
|
|
Feb 23
2023
|
Joseph Simon Former Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,181
-48.71%
|
$427,602
$42.06 P/Share
|
|
Feb 23
2023
|
Joseph Simon Former Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,901
+50.0%
|
-
|
|
Feb 23
2023
|
Christopher Callesano Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,087
-51.1%
|
$45,654
$42.06 P/Share
|
|
Feb 23
2023
|
Christopher Callesano Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,127
+50.0%
|
-
|
|
Feb 23
2023
|
Eric Cantor Vice Chairman, MD |
SELL
Payment of exercise price or tax liability
|
Direct |
19,144
-10.13%
|
$804,048
$42.06 P/Share
|
|
Feb 23
2023
|
Eric Cantor Vice Chairman, MD |
BUY
Exercise of conversion of derivative security
|
Direct |
43,294
+18.64%
|
-
|
|
Feb 22
2023
|
Kenneth Moelis Chairman, CEO |
SELL
Open market or private sale
|
Direct |
45,507
-31.65%
|
$1,911,294
$42.06 P/Share
|
|
Feb 22
2023
|
Kenneth Moelis Chairman, CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
19,798
-12.1%
|
$831,516
$42.06 P/Share
|
|
Feb 22
2023
|
Kenneth Moelis Chairman, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
113,769
+41.02%
|
-
|
|
Feb 22
2023
|
Jeffrey Raich Co-President, MD |
SELL
Open market or private sale
|
Direct |
36,592
-45.01%
|
$1,536,864
$42.06 P/Share
|
|
Feb 22
2023
|
Jeffrey Raich Co-President, MD |
BUY
Exercise of conversion of derivative security
|
Direct |
91,481
+39.43%
|
-
|
|
Feb 22
2023
|
Jeffrey Raich Co-President, MD |
SELL
Payment of exercise price or tax liability
|
Direct |
10,179
-17.4%
|
$427,518
$42.06 P/Share
|
|
Feb 22
2023
|
Elizabeth Crain |
SELL
Open market or private sale
|
Direct |
10,419
-48.25%
|
$437,598
$42.06 P/Share
|
|
Feb 22
2023
|
Elizabeth Crain |
SELL
Payment of exercise price or tax liability
|
Direct |
4,456
-17.1%
|
$187,152
$42.06 P/Share
|
|
Feb 22
2023
|
Elizabeth Crain |
BUY
Exercise of conversion of derivative security
|
Direct |
26,051
+50.0%
|
-
|
|
Feb 22
2023
|
Navid Mahmoodzadegan Co-President, MD |
SELL
Open market or private sale
|
Direct |
68,561
-23.01%
|
$2,879,562
$42.06 P/Share
|
|
Feb 22
2023
|
Navid Mahmoodzadegan Co-President, MD |
BUY
Exercise of conversion of derivative security
|
Direct |
171,406
+23.54%
|
-
|
|
Feb 22
2023
|
Navid Mahmoodzadegan Co-President, MD |
SELL
Payment of exercise price or tax liability
|
Direct |
19,240
-7.51%
|
$808,080
$42.06 P/Share
|
|
Feb 22
2023
|
Osamu R. Watanabe General Counsel, Secretary |
SELL
Open market or private sale
|
Direct |
5,716
-47.72%
|
$240,072
$42.06 P/Share
|
|
Feb 22
2023
|
Osamu R. Watanabe General Counsel, Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
2,446
-16.96%
|
$102,732
$42.06 P/Share
|
|
Feb 22
2023
|
Osamu R. Watanabe General Counsel, Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
14,292
+49.77%
|
-
|